Health-related quality of life (HRQoL) and patient-reported outcomes at final analysis of the TITAN study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).
JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.15, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Özet
- Cilt numarası: 39 Sayı: 15
- Basım Tarihi: 2021
- Doi Numarası: 10.1200/jco.2021.39.15_suppl.5068
- Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır